LearnGlossaryMarketStocksSuperinvestorsSign in

RVMDW

Revolution Medicines, Inc. Warrant

Healthcare · $46.0B market cap

Verdict

We can't put a fair value on RVMDW right now. It looks like a preferred share, note or other security rather than ordinary common stock. The figures we receive belong to the parent company, so they can't value this security.

Business quality

0 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth—?
Equity per share growth1.8% a year✗
Sales growth-10.9% a year✗
Free cash flow growth—?
Return on invested capital-36.8%✗

Follow RVMDW

Track it on your watchlist and see the full analysis. Free.

Create a free account

Superinvestors

1 of the investors we track holds RVMDW. In Q2 2026, 1 opened a position. Who we track

Howard Marks

Oaktree Capital Management · as of Q2 2026

$1.4M

1,150,000 shares

Moves in Q2 2026

New position: Howard Marks

About Revolution Medicines, Inc. Warrant

Revolution Medicines, Inc. is a biopharmaceutical company in the clinical development phase, concentrating on creating innovative, precisely targeted therapies for cancers driven by RAS pathway dysregulation. The firm's drug development portfolio features both RAS(ON) inhibitors, which are designed for potential use as single agents, in conjunction with other RAS(ON) inhibitors, or alongside RAS companion inhibitors…

Biotechnology

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works